Author:
Pratley Richard E,Nauck Michael A,Barnett Anthony H,Feinglos Mark N,Ovalle Fernando,Harman-Boehm Illana,Ye June,Scott Rhona,Johnson Susan,Stewart Murray,Rosenstock Julio
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference22 articles.
1. The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes;Drucker;Lancet,2006
2. Long-acting glucagon-like peptide 1 receptor agonists: a review of their efficacy and tolerability;Garber;Diabetes Care,2011
3. Pharmacodynamics, pharmacokinetics, safety, and tolerability of albiglutide, a long-acting glucagon-like peptide-1 mimetic, in patients with type 2 diabetes;Matthews;J Clin Endocrinol Metab,2008
4. Potential of albiglutide, a long-acting GLP-1 receptor agonist, in type 2 diabetes: a randomized controlled trial exploring weekly, biweekly, and monthly dosing;Rosenstock;Diabetes Care,2009
5. Albiglutide;Rosenstock;Drugs Fut,2010
Cited by
284 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献